The largest database of trusted experimental protocols

5 protocols using sirnacontrol si nc

1

RNA Oligoribonucleotide Synthesis and Sequences

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RNA oligoribonucleotides used in this study, including miR-7 mimic, miR-7 inhibitor, the small interfering RNAs (siRNAs) targeting CDR1as (si-CDR1as) or GDF5 (si-GDF5), and the corresponding miRNA control (miR-NC) and siRNA control (si-NC), were purchased from GenePharma Co. (Shanghai, China). The sequences of these RNA oligoribonucleotides are listed in Additional file 1 (Table S1).
+ Open protocol
+ Expand
2

Modulating circPRRX1 and miR-3064-5p in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small interfering RNA (siRNA) against circPRRX1 (si-circPRRX1), siRNA control (si-NC), miR-3064-5p mimics (miR-3064-5p), mimics control (miR-NC), miR-3064-5p inhibitor (anti-miR-3064-5p), inhibitor control (anti-miR-NC), PTPN14 overexpression vector (PTPN14), and empty overexpression vector (vector) were purchased from GenePharma (Shanghai, China). Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) was used to transfect oligonucleotides or vectors into cells.
+ Open protocol
+ Expand
3

Cell Culture and Transfection Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCC cell line SMMC7721, HepG2, human NK cell line NK-92, and 293T cells were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). SMMC7721, HepG2, and 293T cells were maintained in DMEM with 10% heat-inactivated fetal bovine serum (FBS; Sigma-Aldrich, St. Louis, MO, USA) and 1% penicillin/streptomycin. NK-92 cells were maintained in α-minimum essential medium (Invitrogen, Carlsbad, CA, USA) supplemented with 12.5% FBS (Sigma-Aldrich), 12.5% horse serum (Gibco, Grand Island, NY, USA), 100 U/mL recombinant human IL (rhIL)-2 (PeproTech, Rocky Hill, NJ, USA), and 0.1 mM β-mercaptoethanol. The isolated primary NK cells were cultured in complete RPMI medium (Gibco) supplemented with 10% heat-inactivated FBS (Sigma-Aldrich), 2 mM L-glutamine, and 100 U/mL rhIL-2 (PeproTech). All cells were incubated at 37℃ in an incubator of 5% CO2.
miR-506 mimic (miR-506), miRNA negative control (miR-NC), miR-506 inhibitor (anti-miR-506), inhibitor control (anti-miR-NC), pcDNA-STAT3, pcDNA empty control (pcDNA), siRNA specially against STAT3 (si-STAT3), and siRNA control (si-NC) were purchased from GenePharma (Shanghai, China). NK-92 and primary NK cells were seeded into 96-well plates and transfected with the abovementioned nucleotides or plasmids, using Lipofectamine 2000 (Invitrogen). Co-culturing or RNA extraction was performed 48 hours after transfection.
+ Open protocol
+ Expand
4

Transfection of circTP63 siRNA and miR-217

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell transfection was performed with Lipofectamine 2000 or 3000 Reagent (Invitrogen, CA, USA) according to the manufacturer's protocol. The siRNA sequences for transfection were purchased from GenePharma (Shanghai, China).The sequences for circTP63 was as follows:si-circTP63-1, 5'-GCCAACAGUGAGGGGCCGU-3';si-circTP63-2,5'-CAACAGUGAGGGGCCGUGAGA-3';siRNAcontrol(si-NC)5'-UUCUCCGAACGUGUCACGU-3'.MiR-217mimic, miR-217 inhibitor and miR-NC were obtained from Gene Pharma (Shanghai, China).
+ Open protocol
+ Expand
5

Transfection of circTP63 siRNA and miR-217

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell transfection was performed with Lipofectamine 2000 or 3000 Reagent (Invitrogen, CA, USA) according to the manufacturer's protocol. The siRNA sequences for transfection were purchased from GenePharma (Shanghai, China).The sequences for circTP63 was as follows:si-circTP63-1, 5'-GCCAACAGUGAGGGGCCGU-3';si-circTP63-2,5'-CAACAGUGAGGGGCCGUGAGA-3';siRNAcontrol(si-NC)5'-UUCUCCGAACGUGUCACGU-3'.MiR-217mimic, miR-217 inhibitor and miR-NC were obtained from Gene Pharma (Shanghai, China).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!